Ms. Amy Tang is a Venture Partner at Qiming Venture Partners.
Amy previously worked in Morningside Ventures for 13 years (2002~2015). in charge of its Beijing office. Amy invested and managed dozens of early stage biotech portfolios during this period. Up till now, most of the investments have exited via IPOs or M&A with multiple returns.
Prior to joining Morningside, Amy worked in GSK as a regulatory manager for five years and product manager for two years.
Amy earned her master's degree in Chinese Academy of Sciences and a bachelor's degree from Shen Yang Pharmaceutical University. Amy is also a graduate of EMBA course of Cheung Kong Graduate School of Business (CKGSB).
